Last deal

$2.1M

Amount

Venture - Series Unknown

Stage

25.05.2018

Date

2

all rounds

$3.1M

Total amount

date founded

Financing round

General

About Company
Cend Therapeutics Inc. develops cancer therapies that overcome drug delivery barriers to solid tumors.

Industry

Sector :

Subsector :

Keywords :

Also Known As

DrugCendR Inc.

founded date

01.12.2015

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company's drug delivery platform works specifically in cancer tissues, which maximizes efficacy and minimizes toxicity. Pre-clinical studies have shown efficacy in multiple types of solid tumors, and the mechanism of action is well understood. The technology is undergoing clinical testing in solid tumor patients, and the company uses targeted nanoparticle technologies to enable more effective tumor-targeted, tissue penetrating delivery of nucleic acid-based drugs.
Contacts
Similar Companies
1000
ADC Therapeutics

ADC Therapeutics

ADC Therapeutics is a clinical-stage biotechnology company developing targeted antibody-drug conjugates for the treatment of cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Lausanne, Switzerland

total rounds

11

total raised

$856.55M
Kolltan Pharmaceuticals

Kolltan Pharmaceuticals

Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Internet, Pharmaceuticals

Location

New Haven, CT, USA

total rounds

6

total raised

$146M
HiberCell

HiberCell

HiberCell is a biotech company developing cancer treatments.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New York, NY, USA

total rounds

3

total raised

$158.15M
Sierra Oncology

Sierra Oncology

Sierra Oncology is a late-stage biopharmaceutical company focused on developing targeted therapies for rare forms of cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

San Mateo, CA, USA

total rounds

13

total raised

$494.13M
M&A Details
1

Acquired by

Caladrius Biosciences

announced date

27.04.2022

Financials

Funding Rounds
2
2

Number of Funding Rounds

$3.1M

Money Raised

Their latest funding was raised on 25.05.2018. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
25.05.2018
$2.1M
23.03.2017
$1M
Co-Investors
Acquisitions
1
Acquiree Name 
Date 
Price 
Acquisition Name 
Impilo Pharmaceutical acquired by Cend Therapeutics Inc.

Impilo Pharmaceutical acquired by Cend Therapeutics Inc.

acquirer

Cend Therapeutics Inc.
Cend Therapeutics Inc.

date

21.09.2020

type

Acquisition
Impilo Pharmaceutical

Impilo Pharmaceutical

Impilo Therapeutics is a pharmaceutical company that focuses on developing medicines for women's health.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Pharmaceuticals

Location

Bengaluru, Karnataka, India

People

Founders
3

Kazuki Sugahara

current job

Cend Therapeutics Inc.
Cend Therapeutics Inc.

organization founded

1

Kazuki Sugahara

Erkki Ruoslahti
Erkki Ruoslahti

Erkki Ruoslahti

"Cend aims at transforming the treatment of solid tumor cancers. The Company’s CendR technology takes advantage of a pathway that is normally utilized for nutrient uptake by tissues, and that tumors have hijacked to serve their own nutrient needs . By activating this pathway in tumors, we harness it to specifically enhance drug delivery to tumors. Importantly, the pathway is also active in tumor stroma, converting this major impediment to drug delivery into a conduit for drug entry into tumors."

current job

Cend Therapeutics Inc.
Cend Therapeutics Inc.

organization founded

2

Erkki Ruoslahti

Tambet (Tom) Teesalu
Tambet (Tom) Teesalu

Tambet (Tom) Teesalu

current job

Cend Therapeutics Inc.
Cend Therapeutics Inc.

organization founded

1

Tambet (Tom) Teesalu

Employee Profiles
6
David Slack

David Slack

President & CEO

Harri Jarvelainen

Harri Jarvelainen

COO

Tambet (Tom) Teesalu

Tambet (Tom) Teesalu

Co-Founder, Vice President & Member of Scientific Advisory Board

Kazuki Sugahara

Co-Founder, Vice President & Member of Scientific Advisory Board

Erkki Ruoslahti

Erkki Ruoslahti

Co-Founder & Vice President

Dorr Andrew

Chief Medical Officer (consultant)

Activity

Recent News
1